3'-azido-2',3'-dideoxythymidine 5'-H-phoshonate

01/01/2018 - "[The experience in the application of nikavir in the schemes of perinatal chemoprophylactics of HIV infection: evaluation of the immunological and virusological effectiveness.]"
01/01/2016 - "The above results indicate that both schemes ofantiretroviral activity are 100% efficient as PCP of HIV infection, but phosphazide has an advantage of higher safety and better tolerability."
03/01/2010 - "[Nikavir in chemoprevention regimens for vertical HIV infection transmission]."
01/01/2009 - "The Russian anti-HIV drug nicavir (phosphazide) also proved its high efficacy, that was evident from the results of its use in chemoprophylaxis of perinatal HIV infection transmission in HIV-infected pregnant women. "
03/01/2010 - "In 2007-2008, the Perm Territorial Center for Prevention and Control of AIDS and Communicable Diseases investigated the efficacy of the Russian antiretrovirus drug Nikavir used in various chemoprevention (CP) regimens for perinatal HIV infection, by analyzing epidemiological findings and the results of the clinical and laboratory studies of patients. "

01/01/2017 - "Federation Convincing evidence for high therapeutic activity and tolerability of Phosphazide in the treatment of HIV/AIDS-infection is given. "
03/01/2010 - "In 2007-2008, the Perm Territorial Center for Prevention and Control of AIDS and Communicable Diseases investigated the efficacy of the Russian antiretrovirus drug Nikavir used in various chemoprevention (CP) regimens for perinatal HIV infection, by analyzing epidemiological findings and the results of the clinical and laboratory studies of patients. "
01/01/2017 - "Phosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection."

03/01/2010 - "In 2007-2008, the Perm Territorial Center for Prevention and Control of AIDS and Communicable Diseases investigated the efficacy of the Russian antiretrovirus drug Nikavir used in various chemoprevention (CP) regimens for perinatal HIV infection, by analyzing epidemiological findings and the results of the clinical and laboratory studies of patients. "

01/01/2004 - "The tolerance of nikavir by HIV-infected patients is good and its therapeutic action in HIV-1 infection is marked."
01/01/2017 - "Federation Convincing evidence for high therapeutic activity and tolerability of Phosphazide in the treatment of HIV/AIDS-infection is given. "
01/01/2017 - "Phosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection."

01/01/2017 - "Phosphazide is currently used in various regimens of highly active antiretroviral therapy, as well as in the HIV therapy in patients with simultaneously acquired chronic hepatitis C or tuberculosis. "